Your browser doesn't support javascript.
loading
Plants with Therapeutic Potential for Ischemic Acute Kidney Injury: A Systematic Review.
Ali, Arif; Lima Sampaio, Tiago; Khan, Haroon; Jeandet, Philippe; Küpeli Akkol, Esra; Bahadar, Humaira; Costa Martins, Alice Maria.
Afiliación
  • Ali A; Postgraduation Program in Pharmacology, Federal University of Ceará, Fortaleza, Brazil.
  • Lima Sampaio T; Department of Clinical and Toxicological Analysis, Federal University of Ceará, Fortaleza, Brazil.
  • Khan H; Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
  • Jeandet P; University of Reims Champagne-Ardenne, Research Unit Induced Resistance and Plant Bioprotection, USC INRAe 1488, SFR Condorcet FR CNRS 3417, Faculty of Sciences, Reims 51687, France.
  • Küpeli Akkol E; Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler, Ankara 06330, Turkey.
  • Bahadar H; Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Brazil.
  • Costa Martins AM; Department of Clinical and Toxicological Analysis, Federal University of Ceará, Fortaleza, Brazil.
Article en En | MEDLINE | ID: mdl-35656467
ABSTRACT
Acute kidney injury (AKI) is a complex condition which has an intricate pathology mostly involving hemodynamic, inflammatory, and direct toxic effects at the cellular level with high morbidity and mortality ratios. Renal ischemic reperfusion injury (RIRI) is the main factor responsible for AKI, most often observed in different types of shock, kidney transplantation, sepsis, and postoperative procedures. The RIRI-induced AKI is accompanied by increased reactive oxygen species generation together with the activation of various inflammatory pathways. In this context, plant-derived medicines have shown encouraging nephroprotective properties. Evidence provided in this systemic review leads to the conclusion that plant-derived extracts and compounds exhibit nephroprotective action against renal ischemic reperfusion induced-AKI by increasing endogenous antioxidants and decreasing anti-inflammatory cytokines. However, there is no defined biomarker or target which can be used for treating AKI completely. These plant-derived extracts and compounds are only tested in selected transgenic animal models. To develop the results obtained into a therapeutic entity, one should apply them in proper vertebrate multitransgenic animal models prior to further validation in humans.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Evid Based Complement Alternat Med Año: 2022 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Evid Based Complement Alternat Med Año: 2022 Tipo del documento: Article País de afiliación: Brasil